These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11023153)

  • 1. Screening for type 2 diabetes.
    Engelgau MM; Narayan KM; Herman WH
    Diabetes Care; 2000 Oct; 23(10):1563-80. PubMed ID: 11023153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for type 2 diabetes: literature review and economic modelling.
    Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
    Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
    Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
    BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis.
    Zhang P; Engelgau MM; Valdez R; Cadwell B; Benjamin SM; Narayan KM
    Diabetes Care; 2005 Jun; 28(6):1321-5. PubMed ID: 15920046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.
    Barry E; Roberts S; Oke J; Vijayaraghavan S; Normansell R; Greenhalgh T
    BMJ; 2017 Jan; 356():i6538. PubMed ID: 28052845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
    Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN
    Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
    Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
    J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening adults for pre-diabetes and diabetes may be cost-saving.
    Chatterjee R; Narayan KM; Lipscomb J; Phillips LS
    Diabetes Care; 2010 Jul; 33(7):1484-90. PubMed ID: 20587721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting capillary blood glucose: an appropriate measurement in screening for diabetes and pre-diabetes in low-resource rural settings.
    Zhao X; Zhao W; Zhang H; Li J; Shu Y; Li S; Cai L; Zhou J; Li Y; Hu R
    J Endocrinol Invest; 2013 Jan; 36(1):33-7. PubMed ID: 22453076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.
    JAMA; 1998 Nov; 280(20):1757-63. PubMed ID: 9842951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes primary prevention program: New insights from data analysis of recruitment period.
    Gagliardino JJ; Elgart JF; Bourgeois M; Etchegoyen G; Fantuzzi G; Ré M; Ricart JP; García S; Giampieri C; González L; Suárez-Crivaro F; Kronsbein P; Angelini JM; Martínez C; Martínez J; Ricart A; Spinedi E
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28843031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Prediabetes and Type 2 Diabetes in Asymptomatic Youth: Should HbA1c Be Used as a Diagnostic Approach?
    Vajravelu ME; Lee JM
    Curr Diab Rep; 2018 Jun; 18(7):43. PubMed ID: 29868987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of screening tests for non-insulin-dependent diabetes mellitus.
    Hanson RL; Nelson RG; McCance DR; Beart JA; Charles MA; Pettitt DJ; Knowler WC
    Arch Intern Med; 1993 Sep; 153(18):2133-40. PubMed ID: 8379805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity.
    Dubowitz N; Xue W; Long Q; Ownby JG; Olson DE; Barb D; Rhee MK; Mohan AV; Watson-Williams PI; Jackson SL; Tomolo AM; Johnson TM; Phillips LS
    Diabet Med; 2014 Aug; 31(8):927-35. PubMed ID: 24698119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia.
    Wu EL; Kazzi NG; Lee JM
    JAMA Pediatr; 2013 Jan; 167(1):32-9. PubMed ID: 23403824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
    Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
    Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.